The interplay between chronic inflammation and tumorigenesis: unraveling the inflammation-driven axis.
Inflammatory biomarkers and epigenetic inflammation scores may support cancer risk stratification, early detection, prognostic assessment and treatment monitoring; however, most should be interpreted as complementary laboratory tools rather than stand-alone diagnostic tests, and clinical implementation requires standar...